MLKL and cancer: Taken together, these data suggest that down modulation of RIPK1, RIPK3, or MLKL is associated with poorer prognosis and/or increased tumor aggressiveness, supporting the notion that necroptosis acts as a tumor suppressor and that its repression represents a mechanism for cancer cells to evade cell death.